Results 91 to 100 of about 71,483 (285)

Reactive Infectious Mucocutaneous Eruption (RIME): An Australian Case Series

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative.
Hamish Moore, Emma Ryan, Annabel Stevenson   +2 more
wiley   +1 more source

Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection [PDF]

, 2019
Jeanne Tamarelle, Bing Ma, Pawel Gajer, M Humphrys, Mishka Terplan, Katrina Mark, Anne C. M. Thiébaut, Larry J. Forney, Rebecca M. Brotman, Elisabeth Delarocque‐Astagneau, Patrik M. Bavoil, Jacques Ravel   +11 more
openalex   +1 more source

EBNEO Commentary: The LAKANA Trial: Mass Administration of Azithromycin to Infants in Mali Did Not Reduce Mortality

Acta Paediatrica, EarlyView.
The LAKANA trial: a randomized control trial evaluating the impact of mass administration of azithromycin to infants 1 to 11 months of age in Mali showed no reduction in mortality.
Maya I. Brasher, Monika S. Patil
wiley   +1 more source

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation

Alimentary Pharmacology &Therapeutics, EarlyView.
Gastroparesis occurs in nearly one‐third of lung and heart‐lung transplant recipients (pooled prevalence 31.9%; incidence 25.7%), driven by surgical complexity, perioperative opioid exposure, and diagnostic criteria. Standardized gastric emptying assessment and multidisciplinary management, including opioid minimization, immunosuppressant optimization,
Mohamed H. Eldesouki, Mohamed Mahmoud Marey, Mohamed Ahmed Ali, Amany Mahmoud Genidy, Mohamed Hesham Gamal, Ali M. Othman, Ahmed N. Mohamed, Ahmed Al Qady, Manuel A. Amaris, Amol Sharma   +9 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Prevalence of azithromycin resistance after the COVID-19 era in clinical bacterial isolates from a tertiary care hospital in Gurugram, India

Frontiers in Microbiology
The increasing prevalence of antibiotic resistance in pathogenic bacteria poses a great healthcare problem worldwide. Azithromycin (AZM) is a very effective macrolide antibiotic to treat many bacterial infections, but increasing azithromycin resistance ...
Parbati Debnath, Md Fahim Alam, Manisha Khandait, Fohad Mabood Husain, Nayla Munawar, Aftab Hossain Mondal, Aftab Hossain Mondal   +6 more
doaj   +1 more source

Trueness of Dental Implant Placement Using Dynamic Navigation or Non‐Guided Approach by Novice Surgeons: A Randomized, Controlled Clinical Trial

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To compare the trueness of implant placement in novice surgeons using dynamic computer‐assisted implant surgery (d‐CAIS) versus a non‐guided approach, assessing surgery time efficiency and patient‐reported outcomes, including satisfaction, postoperative pain, and quality of life. Material and Methods A double‐arm randomized clinical
Víctor Ruiz‐Romero, Octavi Camps‐Font, Adria Jorba‐Garcia, Alba Sánchez‐Torres, Rui Figueiredo, Eduard Valmaseda‐Castellón   +5 more
wiley   +1 more source

Bronchiektasen - Nutzen von Azithromycin bei Bronchialveränderungen [PDF]

, 2013
Matthias Manych
openalex   +1 more source

Constitutional symptoms and response to Penicillin G in erysipelas and cellulitis – a monocentric, retrospective, explorative study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Erysipelas, caused by streptococci, should be treated with penicillin, while uncomplicated cellulitis (phlegmon), often caused by Staphylococcus aureus, requires penicillinase‐resistant beta‐lactam antibiotics, which have a higher risk of adverse effects. Distinguishing between these infections is important.
Helena Schieffers, Cord Sunderkötter
wiley   +1 more source

A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women [PDF]

, 2019
Brioni R. Moore, John Benjamin, Roselyn Tobe, Maria Ome‐Kaius, Gumul Yadi, Bernadine Kasian, Charles Kong, Leanne J. Robinson, Moses Laman, Ivo Müeller, Stephen J. Rogerson, Timothy M. E. Davis   +11 more
openalex   +1 more source